Effects of glucagon‐like PEPTIDE‐1 receptor agonists on incidence of hepatocellular carcinoma and liver decompensation in patients with diabetes: A systematic review and META‐analysis
Sign Up to like & getrecommendations! Published in 2025 at "European Journal of Clinical Investigation"
DOI: 10.1111/eci.70000
Abstract: This systematic review and meta‐analysis evaluated the impact of glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) on hepatocellular carcinoma (HCC) and liver decompensation in patients with type 2 diabetes. Analysing over 641,377 patients, GLP‐1RA use was associated… read more here.
Keywords: meta analysis; systematic review; glucagon like; review meta ... See more keywords
Spleen stiffness can predict liver decompensation and survival in patients with cirrhosis
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Gastroenterology and Hepatology"
DOI: 10.1111/jgh.16057
Abstract: Liver stiffness measurement (LSM) has been predicting liver decompensation and survival in cirrhotics. The aim of our study was to investigate if spleen stiffness measurement (SSM) by 2D shear‐wave elastography could predict better the probability… read more here.
Keywords: decompensation; spleen stiffness; decompensation survival; stiffness predict ... See more keywords
Liver decompensation in HIV/Hepatitis B coinfection in the combination antiretroviral therapy era does not seem increased compared to hepatitis B mono‐infection
Sign Up to like & getrecommendations! Published in 2019 at "Liver International"
DOI: 10.1111/liv.14000
Abstract: HIV/hepatitis B virus (HBV) coinfected subjects are thought to have faster progression to end‐stage liver disease (ESLD) than HBV mono‐infected subjects. We assessed whether this remains in the current cART‐era. read more here.
Keywords: hiv hepatitis; hepatitis; era; liver decompensation ... See more keywords